| Original language | English |
|---|---|
| Pages (from-to) | 1393-1419 |
| Number of pages | 27 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 38 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1 2017 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Infection Control and Hospital Epidemiology, Vol. 38, No. 12, 01.12.2017, p. 1393-1419.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Outbreak Response and Incident Management
T2 - SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals
AU - Banach, David B.
AU - Johnston, B. Lynn
AU - Al-Zubeidi, Duha
AU - Bartlett, Allison H.
AU - Bleasdale, Susan Casey
AU - Deloney, Valerie M.
AU - Enfield, Kyle B.
AU - Guzman-Cottrill, Judith A.
AU - Lowe, Christopher
AU - Ostrosky-Zeichner, Luis
AU - Popovich, Kyle J.
AU - Patel, Payal K.
AU - Ravin, Karen
AU - Rowe, Theresa
AU - Shenoy, Erica S.
AU - Stienecker, Roger
AU - Tosh, Pritish K.
AU - Trivedi, Kavita K.
N1 - Funding Information: figure 1. Diagram of incident management preparedness structures and frameworks. This diagram was created by the authors of this expert guidance document to illustrate how US preparedness structures and frameworks relate, starting at the federal level and moving to the facility level. Legend: National Incident Management System (NIMS), National Response Framework (NRF), Emergency Support Function (ESF), Hospital Preparedness Program (HPP), Health Care Coalition (HCC), Crisis Standards of Care (CSC), Hospital Incident Command System (HICS), Emergency Management Program (EMP), Emergency Operations Plan (EOP). Funding Information: Financial support: This manuscript was supported in part by the SHEA Research Network. This guidance was written as part of the SHEA/CDC Outbreak Response Training Program (ORTP contract no. 200-2016-89263). Funding Information: relationships with the NIH and Boston Scientific. C.L. reports research grants/ contracts with Sage Products, LLC, and serves on the Providence Health Care development of a chlorhexidine gluconate QAC and SMR PCR ($10,000). L.O.Z. reports an advisory/consultant role with Astellas, Merck, Cidara, Xenex; honoraria from T2 Biosystems, Pfizer; research grants/contracts with Astellas; organizational relationships with T2 Biosystems, Pfizer, Scynexis; and serves on the IDSA guidelines task force and as Associate Editor JAC. P.K.P. reports research grants/contracts with AHRQ and organizational relationships with CDC/HERT. K.J.P. reports research grants/contracts with NIAID; organizational relationships with CDC, and serves on the IDSA SPGC. E.S.S. reports research grants/contracts with NIAID; organizational relationships with MGH-MIT Grand Challenge; and serves as a member of the IDSA Antimicrobial Resistance Committee and Board member of the Massachusetts Infectious Diseases Society. R.S. reports research grants/contracts with Park-view Health; organizational relationships with Geo-epidemiology and Molecular Characterization of Hepatitis C in Northeastern Indiana A Retrospective Study; and serves on the Board of Directors of Ohio State Medical Association. All other authors report no conflicts of interest relevant to this article.
PY - 2017/12/1
Y1 - 2017/12/1
UR - https://www.scopus.com/pages/publications/85038249035
U2 - 10.1017/ice.2017.212
DO - 10.1017/ice.2017.212
M3 - Article
C2 - 29187263
AN - SCOPUS:85038249035
SN - 0899-823X
VL - 38
SP - 1393
EP - 1419
JO - Infection Control and Hospital Epidemiology
JF - Infection Control and Hospital Epidemiology
IS - 12
ER -